7 employees
Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell.
2014
$13M
from 2 investors over 2 rounds
Cyrano Therapeutics raised $13M on December 10, 2020
Investors: Remiges Ventures, Inc. and Lumira Ventures